PMID- 33583873 OWN - NLM STAT- MEDLINE DCOM- 20220318 LR - 20220325 IS - 1880-3873 (Electronic) IS - 1340-3478 (Print) IS - 1340-3478 (Linking) VI - 29 IP - 3 DP - 2022 Mar 1 TI - Impact of Longer Hemodialysis Vintage with Higher Serum Phosphorus Level on Clinical Outcomes in Patients with Chronic Limb-Threatening Ischemia Presenting Tissue Loss after Endovascular Therapy. PG - 370-378 LID - 10.5551/jat.60095 [doi] AB - AIMS: Hemodialysis vintage and serum phosphorus levels adversely affect outcomes in patients on hemodialysis. Whether these factors have a similar prognostic impact on patients who are on hemodialysis and have chronic limb-threatening ischemia (CLTI) has not been systematically studied. We aimed to explore the risk factors, including hemodialysis vintage and serum phosphorus levels, on clinical outcomes after endovascular therapy (EVT) in hemodialysis patients with CLTI. METHODS: The current study rerospectively analyzed 374 hemodialysis patients with CLTI presenting with ischemic tissue loss (age: 72.3+/-9.0 years, male: 73.3%, diabetes mellitus: 68.2%, Rutherford 5: 75.9%, 6: 24.1%, WIfI stage 4: 50.0%) primarily treated with EVT between April 2007 and December 2016. The primary outcome measure was 1-year amputation-free survival (AFS), while the secondary outcome measure was 1-year wound healing. Predictors for each outcome were evaluated by Cox proportional hazards model. RESULTS: Multivariate analysis significantly associated longer hemodialysis vintages with higher serum phosphorus levels (hazard ratio [HR], 0.599; 95% confidence interval [CI], 0.394-0.910; p=0.016) with 1-year AFS. Longer vintages for hemodialysis with higher serum phosphorus levels were marginally, but not significantly, associated with 1-year wound healing. (HR, 0.684; 95% CI, 0.467-1.000; p=0.050). CONCLUSION: Longer hemodialysis vintages with higher serum phosphorus levels adversely affect outcomes after EVT for hemodialysis patients with CLTI presenting with ischemic tissue loss. FAU - Higashino, Naoko AU - Higashino N AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Iida, Osamu AU - Iida O AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Hata, Yosuke AU - Hata Y AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Asai, Mitsutoshi AU - Asai M AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Masuda, Masaharu AU - Masuda M AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Okamoto, Shin AU - Okamoto S AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Ishihara, Takayuki AU - Ishihara T AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Nanto, Kiyonori AU - Nanto K AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Kanda, Takashi AU - Kanda T AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Tsujimura, Takuya AU - Tsujimura T AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Okuno, Shota AU - Okuno S AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Matsuda, Yasuhiro AU - Matsuda Y AD - Kansai Rosai Hospital Cardiovascular Center. FAU - Takahara, Mitsuyoshi AU - Takahara M AD - Department of Metabolic Medicine and Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine. FAU - Mano, Toshiaki AU - Mano T AD - Kansai Rosai Hospital Cardiovascular Center. LA - eng PT - Journal Article DEP - 20210214 PL - Japan TA - J Atheroscler Thromb JT - Journal of atherosclerosis and thrombosis JID - 9506298 RN - 27YLU75U4W (Phosphorus) SB - IM MH - Aged MH - Chronic Limb-Threatening Ischemia/blood/epidemiology/*etiology MH - Endovascular Procedures/*adverse effects MH - Female MH - Follow-Up Studies MH - Humans MH - Incidence MH - Japan/epidemiology MH - Male MH - Phosphorus/*blood MH - Renal Dialysis MH - Retrospective Studies MH - Risk Assessment/*methods MH - Time Factors PMC - PMC8894118 OTO - NOTNLM OT - Amputation-free survival (AFS) OT - Chronic limb-threatening ischemia (CLTI) OT - Hemodialysis vintage OT - Serum phosphorus level OT - Wound healing EDAT- 2021/02/16 06:00 MHDA- 2022/03/19 06:00 PMCR- 2022/03/01 CRDT- 2021/02/15 06:05 PHST- 2021/02/16 06:00 [pubmed] PHST- 2022/03/19 06:00 [medline] PHST- 2021/02/15 06:05 [entrez] PHST- 2022/03/01 00:00 [pmc-release] AID - DN/JST.JSTAGE/jat/60095 [pii] AID - 10.5551/jat.60095 [doi] PST - ppublish SO - J Atheroscler Thromb. 2022 Mar 1;29(3):370-378. doi: 10.5551/jat.60095. Epub 2021 Feb 14.